EUVIMEDEUVIMED entdecken
Crossref

Nanoparticles of silver and titanium can increase temozolomide sensitivity against human glioblastoma: an in vitro study on apoptosis and inflammation

Sakshi Goswami, Yeshvandra Verma, S V S Rana iD

Naunyn-Schmiedeberg's Archives of Pharmacology · 2025

DOI: 10.1007/s00210-025-04355-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2025. Verfasst von Sakshi Goswami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology, Ch. Charan Singh University, Meerut, 250004, India. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Silver, Titanium. Die Arbeit nennt 48 Literaturangaben. Gefördert von: University Grants Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Temozolomide (TMZ) is one of the alkylating drugs that are preferably employed to treat human glioblastoma (GBM). However, its immune escape and resistance by GBM limit the survival of patients. The present in vitro study was undertaken to investigate whether AgNPs or TiO2NPs can enhance the sensitivity of GBM to TMZ through apoptotic and/or inflammatory responses. Human glioblastoma U87MG cells were exposed to different concentrations of TMZ, AgNPs, and TiO2NPs after determining respective IC50 values for 24 h at 37 °C under a 5% CO2 atmosphere. Thereafter, biomarkers of LPO (malondialdehyde), apoptosis (caspase 3, 9), inflammation (TNF-α and IL-12), and DNA fragmentation (CAD) were assayed. Acridine orange/ethidium bromide staining of GBM was also performed. Combined treatments of GBM with TMZ and AgNPs or TiO2NPs showed a mild stimulatory effect on selected biomarkers of LPO (MDA), apoptosis (caspase3, 9), DNA fragmentation (CAD), and inflammatory cytokines (TNF-α and IL-12) in comparison to those GBM cells treated with TMZ alone. Microscopical results on apoptosis supported these results. It is suggested that overexpression of drug efflux transporters, increased apoptosis, inflammation, and drug delivery directly to cells might have contributed to enhanced protective effects of TMZ, in combination with nanoparticles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaSilverTitaniumMetal NanoparticlesAntineoplastic Agents, AlkylatingBrain NeoplasmsHumansApoptosisCell Line, TumorInflammationDNA Fragmentation

Stichwörter der Autor:innen

GlioblastomaInflammation and apoptosisROSSilver and titanium dioxide nanoparticlesTemozolomide

Substanzen

TemozolomideSilverTitaniumAntineoplastic Agents, Alkylatingtitanium dioxide

Autor:innen und Institutionen

  • Department of Toxicology, Ch. Charan Singh University, Meerut, 250004, India.
  • Department of Toxicology, Ch. Charan Singh University, Meerut, 250004, India. sureshvs_rana@yahoo.com.

ORCID-Profile: S V S Rana

Förderung

  • University Grants Commission

Zitieren

APA

Goswami, S., Verma, Y., & Rana, S. V. S. (2025). Nanoparticles of silver and titanium can increase temozolomide sensitivity against human glioblastoma: an in vitro study on apoptosis and inflammation. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04355-w

Vancouver

Goswami S, Verma Y, Rana SVS. Nanoparticles of silver and titanium can increase temozolomide sensitivity against human glioblastoma: an in vitro study on apoptosis and inflammation. Naunyn-Schmiedeberg's Archives of Pharmacology. 2025. doi:10.1007/s00210-025-04355-w

BibTeX
@article{Goswami2025,
  author = {Goswami, Sakshi and Verma, Yeshvandra and Rana, S V S},
  title = {Nanoparticles of silver and titanium can increase temozolomide sensitivity against human glioblastoma: an in vitro study on apoptosis and inflammation},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2025},
  doi = {10.1007/s00210-025-04355-w}
}
Kostenlos starten →